The COVID-19 pandemic and the use of MS disease-modifying therapies

Uložené v:

Podrobná bibliografia
Vydané v:	Multiple sclerosis and related disorders Ročník 39; s. 102073
Hlavní autori:	Giovannoni, Gavin, Hawkes, Chris, Lechner-Scott, Jeannette, Levy, Michael, Waubant, Emmanuelle, Gold, Julian
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	Netherlands Elsevier B.V 01.04.2020
Predmet:	Betacoronavirus - isolation & purification Coronavirus Infections - epidemiology Coronavirus Infections - immunology Coronavirus Infections - prevention & control COVID-19 Humans Multiple Sclerosis - drug therapy Multiple Sclerosis - epidemiology Multiple Sclerosis - immunology Multiple Sclerosis - virology Neurology Pandemics - prevention & control Pneumonia, Viral - epidemiology Pneumonia, Viral - immunology Pneumonia, Viral - prevention & control SARS-CoV-2
ISSN:	2211-0348, 2211-0356, 2211-0356
On-line prístup:	Získať plný text
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Popis
Bibliografia:	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23
ISSN:	2211-0348 2211-0356 2211-0356
DOI:	10.1016/j.msard.2020.102073